Inhaled heliox does not benefit ED patients withmoderate to severe asthma
Section snippets
To the editor:
Heliox, an inhaled helium-oxygen mixture that typically consists of 80% helium and 20% oxygen, has been considered as a potential treatment in the setting of acute asthma exacerbation. The interest in heliox use has resulted in multiple reports of patients with various obstructive respiratory diseases. However, the impact of heliox in the treatment of acute asthma is currently unclear given the paucity of controlled studies.
This study was designed to evaluate the efficacy of inhaled heliox as
References (13)
- et al.
Use of heliox-driven nebulizer therapy in the treatment of acute asthma
Ann Emer Med
(1999) - et al.
Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of acute asthma
Ann Emer Med
(1998) - et al.
Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial
J Pediatr
(1996) - et al.
Continuous versus intermittent albuterol nebulization in the treatment of acute asthma
Ann Emerg Med
(1993) - et al.
Early corticosteroid administration in acute asthma
Am J Emerg Med
(1997) - et al.
Heliox therapy in acute severe asthma
Chest
(1995)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2000 W.B. Saunders Company. All rights reserved.